Ratcliffe J, Thomas K J, MacPherson H, Brazier J
School of Health and Related Research, University of Sheffield.
BMJ. 2006 Sep 23;333(7569):626. doi: 10.1136/bmj.38932.806134.7C. Epub 2006 Sep 15.
To evaluate the cost effectiveness of acupuncture in the management of persistent non-specific low back pain.
Cost effectiveness analysis of a randomised controlled trial.
Three private acupuncture clinics and 18 general practices in York, England.
241 adults aged 18-65 with non-specific low back pain of 4-52 weeks' duration.
Ten individualised acupuncture treatments over three months from acupuncturists trained in traditional Chinese medicine (n = 160) or usual care only (n = 81).
Incremental cost per quality adjusted life year (QALY) gained over two years.
Total costs to the United Kingdom's health service during the two year study period were higher on average for the acupuncture group (460 pounds sterling; 673 euros; 859 dollars) than for the usual care group (345 pounds sterling) because of the costs associated with initial treatment. The mean incremental health gain from acupuncture at 12 months was 0.012 QALYs (95% confidence interval -0.033 to 0.058) and at 24 months was 0.027 QALYs (-0.056 to 0.110), leading to a base case estimate of 4241 pounds sterling per QALY gained. This result was robust to sensitivity analysis. The probabilistic sensitivity analysis showed acupuncture to have a more than 90% chance of being cost effective at a pound20 000 cost per QALY threshold.
A short course of traditional acupuncture for persistent non-specific low back pain in primary care confers a modest health benefit for minor extra cost to the NHS compared with usual care. Acupuncture care for low back pain seems to be cost effective in the longer term.
ISRCTN80764175 [controlled-trials.com].
评估针刺疗法治疗持续性非特异性下腰痛的成本效益。
一项随机对照试验的成本效益分析。
英国约克郡的三家私人针灸诊所和18家普通诊所。
241名年龄在18至65岁之间、患有持续4至52周非特异性下腰痛的成年人。
接受由受过中医培训的针灸师进行的为期三个月的十次个体化针刺治疗(n = 160)或仅接受常规护理(n = 81)。
两年内每获得一个质量调整生命年(QALY)的增量成本。
在为期两年的研究期间,由于初始治疗相关成本,针刺组英国国民医疗服务体系(NHS)的总成本平均(460英镑;673欧元;859美元)高于常规护理组(345英镑)。针刺疗法在12个月时的平均增量健康收益为0.012个QALY(95%置信区间为-0.033至0.058),在24个月时为0.027个QALY(-0.056至0.110),得出每获得一个QALY的基础病例估计成本为4241英镑。该结果对敏感性分析具有稳健性。概率敏感性分析表明,在每QALY阈值成本为20000英镑时,针刺疗法具有超过90%的成本效益可能性。
与常规护理相比,在初级保健中对持续性非特异性下腰痛进行短期的传统针刺治疗,可为NHS带来适度的健康益处,但成本略有增加。从长远来看,针刺疗法治疗下腰痛似乎具有成本效益。
ISRCTN80764175 [controlled-trials.com]